Compile Data Set for Download or QSAR
Report error Found 468 Enz. Inhib. hit(s) with Target = 'Ubiquitin carboxyl-terminal hydrolase 30 [57-517]'
LigandPNGBDBM592760(US11572374, Example 12-6 | 2-chloro-N-(8-cyano-8- ...)
Affinity DataIC50: 10nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592741(US11572374, Example 7-3 | (3S)-6-chloro-N-((1R,2R,...)
Affinity DataIC50: 17nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592645((3S)-6-chloro-N-((1R,2R,4S)-7-cyano-7- azabicyclo[...)
Affinity DataIC50: 20nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592753(US11572374, Example 7-15 | 1-((1R,2R,4S)-7-cyano-7...)
Affinity DataIC50: 22nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592927(US11572374, Example 30-7 | (3S)-1-(3-chloro-5-meth...)
Affinity DataIC50: 25nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592951(US11572374, Example 12-2-3)
Affinity DataIC50: 25nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592654(6-chloro-N-((1R,2R,4S)-7-cyano-7- azabicyclo[2.2.1...)
Affinity DataIC50: 26nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592779(US11572374, Example 12-25 | (3E)-N-((1R,2R,4S)-7-c...)
Affinity DataIC50: 26nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592826(US11572374, Example 20-14 | 3-chloro-N-((1R,2R,4S)...)
Affinity DataIC50: 26nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592735(US11572374, Example 2-63 | 3-chloro-N-((1R,2R,4S)-...)
Affinity DataIC50: 27nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592861(US11572374, Example 20-49 | 2-chloro-N-((1R,2R,4S)...)
Affinity DataIC50: 27nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592819(US11572374, Example 20-7 | 3-chloro-N-((1R,2R,4S)-...)
Affinity DataIC50: 28nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592920(US11572374, Example 29-7 | (3S)-1-(3-chloro-6-(tri...)
Affinity DataIC50: 29nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592926(US11572374, Example 30-6 | (3S)-1-(3-chloro-5-(tri...)
Affinity DataIC50: 29nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592827(US11572374, Example 20-15 | 3-chloro-N-((1R,2R,4S)...)
Affinity DataIC50: 30nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592697(2-chloro-N-((1R,2R,4S)-7-cyano-7- azabicyclo[2.2.1...)
Affinity DataIC50: 31nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592775(US11572374, Example 12-21 | (3E)-N-((1R,2R,4S)-7-c...)
Affinity DataIC50: 34nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592755(US11572374, Example 7-17 | 2-chloro-N-((1R,2R,4S)-...)
Affinity DataIC50: 37nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592924(US11572374, Example 30-4 | (3S)-N-((1R,2R,4S)-7-cy...)
Affinity DataIC50: 37nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592781(US11572374, Example 12-27 | (2E)-3-(5-chloro-1-ben...)
Affinity DataIC50: 38nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592839(US11572374, Example 20-27 | N-((1R,2R,4S)-7-cyano-...)
Affinity DataIC50: 39nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592778(US11572374, Example 12-24 | (2E)-3-(5-chloro-1-eth...)
Affinity DataIC50: 40nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592837(US11572374, Example 20-25 | 3-chloro-N-((1R,2R,4S)...)
Affinity DataIC50: 41nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592782(US11572374, Example 12-28 | 3'-bromo-N-((1R,2R,4S)...)
Affinity DataIC50: 44nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592940(US11572374, Example 32-1 | (3S)-1-(3-chloro-5-cyan...)
Affinity DataIC50: 44nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592714(US11572374, Example 2-42 | 2-chloro-N-((1R,2R,4S)-...)
Affinity DataIC50: 46nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592912(US11572374, Example 28-1 | (3S)-N-((1R,2R,4S)-7-cy...)
Affinity DataIC50: 46nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592822(US11572374, Example 20-10 | 3-chloro-N-((1R,2R,4S)...)
Affinity DataIC50: 47nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592805(US11572374, Example 15-12-2 | (1S,4R,5S)-N-((1R,2R...)
Affinity DataIC50: 48nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592829(US11572374, Example 20-17 | 3-chloro-N-((1R,2R,4S)...)
Affinity DataIC50: 49nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592886(US11572374, Example 20-74 | N-((1R,2R,4S)-7-cyano-...)
Affinity DataIC50: 50nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592968(US11572374, Example 20-77 | N-((1R,2R,4S)-7-cyano-...)
Affinity DataIC50: 50nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592777(US11572374, Example 12-23 | (3E)-4-(3-chlorophenyl...)
Affinity DataIC50: 54nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592913(US11572374, Example 28-2 | (3S)-1-(5-chloro-2-cyan...)
Affinity DataIC50: 54nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592937(US11572374, Example 30-17 | (3S)-N-((1R,2R,4S)-7-c...)
Affinity DataIC50: 54nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592816(US11572374, Example 20-4 | 3,3'-dichloro-N-((1R,2R...)
Affinity DataIC50: 55nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592818(US11572374, Example 20-6 | 3,4'-dichloro-N-((1R,2R...)
Affinity DataIC50: 55nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592765(US11572374, Example 12-11 | N-((1R,2R,4S)-7-cyano-...)
Affinity DataIC50: 56nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592759(US11572374, Example 12-5 | 6-(((1-(4- bromophenyl)...)
Affinity DataIC50: 57nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592808(US11572374, Example 15-15 | 6-chloro-N-((1R,2R,4S)...)
Affinity DataIC50: 57nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592880(US11572374, Example 20-68 | N-((1R,2R,4S)-7-cyano-...)
Affinity DataIC50: 58nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592918(US11572374, Example 29-5 | (3S)-N-((1R,2R,4S)-7-cy...)
Affinity DataIC50: 58nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592815(US11572374, Example 20-3 | 2',3-dichloro-N-((1R,2R...)
Affinity DataIC50: 60nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592674(2-chloro-N-((1R,2R,4S)-7-cyano-7- azabicyclo[2.2.1...)
Affinity DataIC50: 61nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592694(3-chloro-N-((1R,2R,4S)-7-cyano-7- azabicyclo[2.2.1...)
Affinity DataIC50: 62nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592934(US11572374, Example 30-14 | (3S)-N-((1R,2R,4S)-7-c...)
Affinity DataIC50: 62nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592947(US11572374, Example 33-1-2 | (1R,4R,5R)-N-((1R,2R,...)
Affinity DataIC50: 62nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592742(US11572374, Example 7-4 | N-((1R,2R,4S)-7-cyano-7-...)
Affinity DataIC50: 64nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592764(US11572374, Example 12-10 | US11572374, Example 12...)
Affinity DataIC50: 64nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM592944(US11572374, Example 32-5 | (3S)-N-((1R,2R,4S)-7-cy...)
Affinity DataIC50: 64nMAssay Description:USP30 inhibition was tested with recombinant human USP30 using the fluorescent substrate Ubiquitin-Rhodamine 110 (UBPBio) in 1536-well format. Compou...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 468 total ) | Next | Last >>
Jump to: